Stockmann Group's preliminary revenue in December and for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Stockmann Group's preliminary revenue in December and for full year 2014

STOCKMANN plc, Company Announcement 9.1.2015 at 11:00 EET

The Stockmann Group’s preliminary revenue was down 11.6 per cent on the previous year and amounted to EUR 205.0 million in December 2014. The decline was mainly due to currency effects, mainly the Russian rouble, which weakened 55 per cent on the previous year compared to the euro. Revenue at comparable exchange rates was down 5.2 per cent.

The Department Store Division’s revenue was up 20 per cent on the previous year in Russia in rouble. Due to the very weak exchange rate of the rouble, euro-denominated revenue was down 24 per cent in Russia. In Finland and in the Baltic countries, Christmas sales were below the level for 2013 in all units except the Stockmann online store. The division’s total euro-denominated revenue decreased by 11.4 per cent; down 8.2 per cent in Finland and 19.4 per cent in international operations.

Lindex’s revenue in local currencies was on a par with the previous year or down 9.9 per cent in euro-denominated revenue. Seppälä’s revenue was down 24.1 per cent or down 13.1 per cent in comparable stores, excluding the closed 33 stores in 2014. The Fashion Chain Division’s total revenue decreased by 12.0 per cent; down 10.2 per cent in Finland and 12.5 per cent in international operations.

Revenue for 2014

The Stockmann Group’s preliminary revenue for the full year 2014 amounted to EUR 1 841.3 million. Revenue was down 9.5 per cent on the previous year, or down 5.6 per cent at comparable exchange rates.

The Department Store Division’s revenue was down 10.5 per cent. Revenue was up in the Baltic countries and in local currency in the Russian department stores, but euro-denominated revenue in international operations was down 11.0 per cent. Revenue was down 10.2 per cent in Finland.

Lindex’s revenue in local currencies was on a par with the previous year or down 5.8 per cent in euro-denominated revenue. Seppälä’s revenue was down 21.3 per cent. The Fashion Chain Division’s revenue was down 8.1 per cent; down 9.3 per cent in Finland and down 7.8 per cent in international operations.

Stockmann will publish its financial statements bulletin for 2014 on 13 February 2015 at 8:00 EET. The company’s financial statements, the report by the Board of Directors and an electronic version of the Annual Report 2014 will be published in the week starting on 23 February 2015.


Revenue (exclusive of VAT) in December

  12/2014
EUR mill.
Change-%
Department Store Division, Finland 94.0 -8.2
Department Store Division,
international operations
33.0 -19.4
Department Store Division, total 127.0 -11.4
Fashion Chain Division, Finland 16.0 -10.2
Fashion Chain Division,
international operations
61.9 -12.5
Fashion Chain Division, total 77.9 -12.0
Unallocated 0.0  
Operations in Finland, total 110.0 -8.4
International operations, total 95.0 -15.0
Stockmann total 205.0 -11.6



Revenue (exclusive of VAT) in January-December

  1-12/2014
EUR mill.
Change-%
excl. terminated franchising*
Change-%
Department Store Division, Finland 745.5 -10.2 -10.6
Department Store Division,
international operations
355.1 -11.0 -11.0
Department Store Division, total 1 100.6 -10.5 -10.7
Fashion Chain Division, Finland 136.5 -9.3 -9.3
Fashion Chain Division,
international operations
603.9 -7.8 -7.8
Fashion Chain Division, total 740.4 -8.1 -8.1
Unallocated 0.3    
Operations in Finland, total 882.3 -10.0 -10.3
International operations, total 958.9 -9.0 -9.0
Stockmann total 1 841.3 -9.5 -9.6


Change-%: change compared with the corresponding period of the previous year.
*Change compared with the revenue excluding the Zara franchising operations in Finland which were terminated on 1 March 2013.

Further information:
Pekka Vähähyyppä, CFO, tel. +358 9 121 3351
Nora Malin, Director, Corporate Communications, tel. +358 9 121 3558


www.stockmanngroup.com


STOCKMANN plc

Nora Malin
Director, Corporate Communications


Distribution:
NASDAQ OMX
Principal media

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading